Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net loss	$ (38,740)	$ (9,285)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	6,015	6,483
Amortization of operating lease right-of-use assets	475	582
Impairment loss on intangible assets and goodwill	2,021
Loss on sale and impairment of property, equipment, and software	4	70
Gain on remeasurement of private warrant liability	(345)	(10,189)
Loss (gain) on remeasurement of contingent consideration	(154)	3,205
Gain on remeasurement of earnout liability		(11,179)
Stock-based compensation	6,894	5,854
Amortization of investment premium/accretion of discount, net	(280)	566
Net realized losses on investments	67	68
Interest expense (non-cash)	1,534	1,046
Other	242	64
Change in operating assets and liabilities, net of acquisitions and divestitures
Accounts receivable	2,619	1,312
Reinsurance balance due	6,286	(7,920)
Prepaid expenses and other current assets	(10,826)	(6,415)
Accounts payable	(69)	1,051
Accrued expenses and other current liabilities	1,390	(4,033)
Losses and loss adjustment expense reserves	14,895	17,659
Other insurance liabilities, current	16,712	3,025
Deferred revenue	(24,100)	(1,945)
Refundable customer deposits	(4,607)	(2,949)
Long-term insurance commissions receivable	(875)	(1,540)
Operating lease liabilities, non-current	(489)	(235)
Other	(700)	(696)
Net cash used in operating activities	(22,031)	(15,401)
Cash flows from investing activities:
Purchases of property and equipment	(356)	(1,167)
Capitalized internal use software development costs	(2,427)	(1,574)
Purchases of short-term and long-term investments	(5,410)	(8,835)
Maturities, sales of short-term and long-term investments	5,020	8,449
Acquisitions, net of cash acquired	(1,974)	(4,950)
Net cash used in investing activities	(5,147)	(8,077)
Cash flows from financing activities:
Proceeds from advance funding	313	5,143
Repayments of advance funding	(1,281)	(3,033)
Repayments of principal and related fees	(499)	(150)
Proceeds from exercises of stock options	8	473
Income tax withholdings paid upon vesting of restricted stock units	(204)	(712)
Payments of acquisition-related contingent consideration	(194)
Repurchase of stock	(5,608)
Proceeds from sale of common stock	191
Net cash provided by financing activities	(7,274)	1,721
Net change in cash, cash equivalents, and restricted cash	(34,452)	(21,757)
Cash, cash equivalents, and restricted cash, beginning of period	228,605	324,792
Cash, cash equivalents, and restricted cash end of period	194,153	303,035
Supplemental disclosures
Cash paid for interest	1,796	$ 1,587
Income tax refunds received	$ 2,380